NEWSpublisher 2007 :: AngloChinese Investments
date from:
date to:
search for string:
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS back to previous page show list
»02/03/2007 [Company watch]
AXM Pharma acquires Chinese Research Institute

Shenyang based AXM Pharma, a manufacturer of proprietry and generic pharmaceutical products for China and other Asian markets will acquire Beijing Yuhuatang Biological Sci-Tech Development, a leading chinese research institute


AXM has acquired the business to increase its product lines.  BYB  produces a broad range of products including testosterone and testosterone undecanoate, benefitting from Government grants and innovation funding.  Androstenedione, contained in the product is in great demand, outstripping supply.

AXM's 60,000 sq feet GMP facility will produce these from the autumn of 2007.  A new facility is being constructed in compliance with FDA and GMP compliance and products will be exported as well as sold in China.

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.